Skip to main content
Educational use only — not medical advice

Research library

CJC-1295 (without DAC) benefits

From the PeptideBase research library. Educational only — not medical advice.

Studied effects

  • GH and IGF-1 elevation
  • sustained GHRH receptor agonism
  • body composition support
  • recovery enhancement
  • GH axis restoration

Mechanism

CJC-1295 without DAC (Mod GRF 1-29) is a short-acting GHRH analog that binds and activates pituitary GHRH receptors to stimulate brief, pulsatile growth hormone release. Lacking the Drug Affinity Complex, it is not albumin-bound and clears within roughly half an hour, producing discrete GH pulses rather than the sustained elevation of the DAC form.

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.

Free Guide

The Peptide Research Digest

Get our free provider vetting guide — plus weekly research briefings on peptide sourcing, COA verification, and clinical developments.

No spam.